TY - JOUR AU - Gregoire, V. AU - Lefebvre, J. L. AU - Licitra, L. AU - Felip, E. PY - 2010 DA - 2010// TI - Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up JO - Ann Oncol VL - 21 UR - https://doi.org/10.1093/annonc/mdq185 DO - 10.1093/annonc/mdq185 ID - Gregoire2010 ER - TY - JOUR AU - Marur, S. AU - Forastiere, A. A. PY - 2016 DA - 2016// TI - Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment JO - Mayo Clin Proc VL - 91 UR - https://doi.org/10.1016/j.mayocp.2015.12.017 DO - 10.1016/j.mayocp.2015.12.017 ID - Marur2016 ER - TY - JOUR AU - Pignon, J. P. AU - Maitre, A. AU - Maillard, E. AU - Bourhis, J. PY - 2009 DA - 2009// TI - Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients JO - Radiother Oncol VL - 92 UR - https://doi.org/10.1016/j.radonc.2009.04.014 DO - 10.1016/j.radonc.2009.04.014 ID - Pignon2009 ER - TY - JOUR AU - Forastiere, A. A. AU - Zhang, Q. AU - Weber, R. S. AU - Maor, M. H. AU - Goepfert, H. AU - Pajak, T. F. PY - 2013 DA - 2013// TI - Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/jco.2012.43.6097 DO - 10.1200/jco.2012.43.6097 ID - Forastiere2013 ER - TY - JOUR AU - Vermorken, J. B. AU - Remenar, E. AU - Herpen, C. AU - Gorlia, T. AU - Mesia, R. AU - Degardin, M. PY - 2007 DA - 2007// TI - Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer JO - N Engl J Med VL - 357 UR - https://doi.org/10.1056/NEJMoa071028 DO - 10.1056/NEJMoa071028 ID - Vermorken2007 ER - TY - JOUR AU - Posner, M. R. AU - Hershock, D. M. AU - Blajman, C. R. AU - Mickiewicz, E. AU - Winquist, E. AU - Gorbounova, V. PY - 2007 DA - 2007// TI - Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer JO - N Engl J Med VL - 357 UR - https://doi.org/10.1056/NEJMoa070956 DO - 10.1056/NEJMoa070956 ID - Posner2007 ER - TY - JOUR AU - Hitt, R. AU - Grau, J. J. AU - Lopez-Pousa, A. AU - Berrocal, A. AU - Garcia-Giron, C. AU - Irigoyen, A. PY - 2014 DA - 2014// TI - A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer JO - Ann Oncol VL - 25 UR - https://doi.org/10.1093/annonc/mdt461 DO - 10.1093/annonc/mdt461 ID - Hitt2014 ER - TY - JOUR AU - Cohen, E. E. AU - Karrison, T. G. AU - Kocherginsky, M. AU - Mueller, J. AU - Egan, R. AU - Huang, C. H. PY - 2014 DA - 2014// TI - Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/jco.2013.54.6309 DO - 10.1200/jco.2013.54.6309 ID - Cohen2014 ER - TY - JOUR AU - Ghi, M. G. AU - Paccagnella, A. AU - Ferrari, D. AU - Foa, P. AU - Alterio, D. AU - Codeca, C. PY - 2017 DA - 2017// TI - Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II-III trial JO - Ann Oncol VL - 28 UR - https://doi.org/10.1093/annonc/mdx299 DO - 10.1093/annonc/mdx299 ID - Ghi2017 ER - TY - JOUR AU - Haddad, R. I. AU - Posner, M. AU - Hitt, R. AU - Cohen, E. E. W. AU - Schulten, J. AU - Lefebvre, J. L. PY - 2018 DA - 2018// TI - Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions JO - Ann Oncol VL - 29 UR - https://doi.org/10.1093/annonc/mdy102 DO - 10.1093/annonc/mdy102 ID - Haddad2018 ER - TY - JOUR AU - Kenmotsu, H. AU - Tanigawara, Y. PY - 2015 DA - 2015// TI - Pharmacokinetics, dynamics and toxicity of docetaxel: why the Japanese dose differs from the Western dose JO - Cancer Sci VL - 106 UR - https://doi.org/10.1111/cas.12647 DO - 10.1111/cas.12647 ID - Kenmotsu2015 ER - TY - JOUR AU - Tije, A. J. AU - Verweij, J. AU - Carducci, M. A. AU - Graveland, W. AU - Rogers, T. AU - Pronk, T. PY - 2005 DA - 2005// TI - Prospective evaluation of the pharmacokinetics and toxicity profile of docetaxel in the elderly JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/jco.2005.03.082 DO - 10.1200/jco.2005.03.082 ID - Tije2005 ER - TY - JOUR AU - Yano, R. AU - Konno, A. AU - Watanabe, K. AU - Tsukamoto, H. AU - Kayano, Y. AU - Ohnaka, H. PY - 2013 DA - 2013// TI - Pharmacoethnicity of docetaxel-induced severe neutropenia: integrated analysis of published phase II and III trials JO - Int J Clin Oncol VL - 18 UR - https://doi.org/10.1007/s10147-011-0349-5 DO - 10.1007/s10147-011-0349-5 ID - Yano2013 ER - TY - JOUR AU - Ahn, J. S. AU - Cho, S. H. AU - Kim, O. K. AU - Lee, J. K. AU - Yang, D. H. AU - Kim, Y. K. PY - 2007 DA - 2007// TI - The efficacy of an induction chemotherapy combination with docetaxel, cisplatin, and 5-FU followed by concurrent chemoradiotherapy in advanced head and neck cancer JO - Cancer Res Treat VL - 39 UR - https://doi.org/10.4143/crt.2007.39.3.93 DO - 10.4143/crt.2007.39.3.93 ID - Ahn2007 ER - TY - JOUR AU - Okano, S. AU - Enokida, T. AU - Onoe, T. AU - Ota, Y. AU - Motegi, A. AU - Zenda, S. PY - 2019 DA - 2019// TI - Induction TPF chemotherapy followed by CRT with fractionated administration of cisplatin in patients with unresectable locally advanced head and neck cancer JO - Int J Clin Oncol VL - 24 UR - https://doi.org/10.1007/s10147-019-01418-w DO - 10.1007/s10147-019-01418-w ID - Okano2019 ER - TY - JOUR AU - Citron, M. L. AU - Berry, D. A. AU - Cirrincione, C. AU - Hudis, C. AU - Winer, E. P. AU - Gradishar, W. J. PY - 2003 DA - 2003// TI - Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of intergroup trial C9741/Cancer and leukemia group B trial 9741 JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/jco.2003.09.081 DO - 10.1200/jco.2003.09.081 ID - Citron2003 ER - TY - JOUR AU - Demirci, N. S. AU - Aksoy, S. AU - Özdemir, N. Y. AU - Erdem, G. U. AU - Ozcelik, M. AU - Tanrikulu, E. PY - 2017 DA - 2017// TI - Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study JO - Curr Med Res Opin VL - 33 UR - https://doi.org/10.1080/03007995.2016.1257984 DO - 10.1080/03007995.2016.1257984 ID - Demirci2017 ER - TY - JOUR AU - Iyer, G. AU - Balar, A. V. AU - Milowsky, M. I. AU - Bochner, B. H. AU - Dalbagni, G. AU - Donat, S. M. PY - 2018 DA - 2018// TI - Multicenter prospective phase II trial of Neoadjuvant dose-dense gemcitabine plus Cisplatin in patients with muscle-invasive bladder Cancer JO - J Clin Oncol VL - 36 UR - https://doi.org/10.1200/jco.2017.75.0158 DO - 10.1200/jco.2017.75.0158 ID - Iyer2018 ER - TY - JOUR AU - Kanda, Y. PY - 2013 DA - 2013// TI - Investigation of the freely available easy-to-use software 'EZR' for medical statistics JO - Bone Marrow Transplant VL - 48 UR - https://doi.org/10.1038/bmt.2012.244 DO - 10.1038/bmt.2012.244 ID - Kanda2013 ER - TY - JOUR AU - Haddad, R. AU - O'Neill, A. AU - Rabinowits, G. AU - Tishler, R. AU - Khuri, F. AU - Adkins, D. PY - 2013 DA - 2013// TI - Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial JO - Lancet Oncol VL - 14 UR - https://doi.org/10.1016/s1470-2045(13)70011-1 DO - 10.1016/s1470-2045(13)70011-1 ID - Haddad2013 ER - TY - JOUR AU - Wang, H. M. AU - Lin, C. Y. AU - Hsieh, C. H. AU - Hsu, C. L. AU - Fan, K. H. AU - Chang, J. T. PY - 2017 DA - 2017// TI - Induction chemotherapy with dose-modified docetaxel, cisplatin, and 5-fluorouracil in Asian patients with borderline resectable or unresectable head and neck cancer JO - J Formos Med Assoc VL - 116 UR - https://doi.org/10.1016/j.jfma.2016.03.005 DO - 10.1016/j.jfma.2016.03.005 ID - Wang2017 ER - TY - JOUR AU - Fayette, J. AU - Fontaine-Delaruelle, C. AU - Ambrun, A. AU - Daveau, C. AU - Poupart, M. AU - Ramade, A. PY - 2016 DA - 2016// TI - Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.8934 DO - 10.18632/oncotarget.8934 ID - Fayette2016 ER - TY - JOUR AU - Hervonen, P. AU - Joensuu, H. AU - Joensuu, T. AU - Ginman, C. AU - McDermott, R. AU - Harmenberg, U. PY - 2012 DA - 2012// TI - Biweekly docetaxel is better tolerated than conventional three-weekly dosing for advanced hormone-refractory prostate cancer JO - Anticancer Res VL - 32 ID - Hervonen2012 ER - TY - JOUR AU - Beerblock, K. AU - Rinaldi, Y. AU - André, T. AU - Louvet, C. AU - Raymond, E. AU - Tournigand, C. PY - 1997 DA - 1997// TI - Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous infusion in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les cancers de l'Ovaire et Digestifs (GERCOD) JO - Cancer VL - 79 UR - https://doi.org/3.0.CO;2-J DO - 3.0.CO;2-J ID - Beerblock1997 ER - TY - JOUR AU - Yeh, K. H. AU - Yeh, S. H. AU - Hsu, C. H. AU - Wang, T. M. AU - Ma, I. F. AU - Cheng, A. L. PY - 2000 DA - 2000// TI - Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracil JO - Br J Cancer VL - 83 UR - https://doi.org/10.1054/bjoc.2000.1456 DO - 10.1054/bjoc.2000.1456 ID - Yeh2000 ER - TY - JOUR AU - Reinisch, M. AU - Ataseven, B. AU - Kümmel, S. PY - 2016 DA - 2016// TI - Neoadjuvant dose-dense and dose-intensified chemotherapy in breast Cancer - review of the literature JO - Breast Care (Basel) VL - 11 UR - https://doi.org/10.1159/000444543 DO - 10.1159/000444543 ID - Reinisch2016 ER - TY - JOUR AU - Lyman, G. H. AU - Barron, R. L. AU - Natoli, J. L. AU - Miller, R. M. PY - 2012 DA - 2012// TI - Systematic review of efficacy of dose-dense versus non-dose-dense chemotherapy in breast cancer, non-Hodgkin lymphoma, and non-small cell lung cancer JO - Crit Rev Oncol Hematol VL - 81 UR - https://doi.org/10.1016/j.critrevonc.2011.04.010 DO - 10.1016/j.critrevonc.2011.04.010 ID - Lyman2012 ER - TY - JOUR AU - Kiong, K. L. AU - Souza, N. N. AU - Sultana, R. AU - Iyer, N. G. PY - 2018 DA - 2018// TI - Meta-analysis of induction chemotherapy as a selection marker for chemoradiation in the head and neck JO - Laryngoscope VL - 128 UR - https://doi.org/10.1002/lary.27011 DO - 10.1002/lary.27011 ID - Kiong2018 ER - TY - JOUR AU - Inhestern, J. AU - Schmalenberg, H. AU - Dietz, A. AU - Rotter, N. AU - Maschmeyer, G. AU - Jungehulsing, M. PY - 2017 DA - 2017// TI - A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1) JO - Ann Oncol VL - 28 UR - https://doi.org/10.1093/annonc/mdx202 DO - 10.1093/annonc/mdx202 ID - Inhestern2017 ER - TY - JOUR AU - Anjos, R. F. AU - Anjos, D. A. AU - Vieira, D. L. AU - Leite, A. F. AU - Figueiredo, P. T. AU - Melo, N. S. PY - 2016 DA - 2016// TI - Effectiveness of FDG-PET/CT for evaluating early response to induction chemotherapy in head and neck squamous cell carcinoma: a systematic review JO - Medicine (Baltimore) VL - 95 UR - https://doi.org/10.1097/md.0000000000004450 DO - 10.1097/md.0000000000004450 ID - Anjos2016 ER -